RxE2 Inc specializes in decentralized clinical trials by integrating pharmacy practice into all aspects of the trial process. This approach allows local pharmacists to leverage their patient insights to enhance accessibility for participants, streamline trial operations, and reduce costs. By involving pharmacists as medication experts, RxE2 aims to provide more accurate data for study sponsors and improve the overall efficiency of clinical trials. in 2021, RxE2 established a local R&D center following the acquisition of Habitu, which integrated the activity of the Start-Up into the global company.